Table 1 Summary of Demographic Data and Disease Characteristics at Baseline (all randomized subjects)
Desloratadine | ||||||
|---|---|---|---|---|---|---|
Characteristic | 2.5 mg (n = 173) | 5 mg (n = 172) | 7.5 mg (n = 173) | 10 mg (n = 172) | 20 mg (n = 172) | Placebo (n = 174) |
Mean (range) age, years | 34 (13–73) | 34 (12–75) | 34 (12–73) | 34 (12–70) | 34 (12–72) | 35 (12–63) |
Age group, years | ||||||
12–17 | 22 | 26 | 25 | 28 | 25 | 22 |
18–65 | 150 | 143 | 145 | 143 | 145 | 152 |
>65 | 1 | 3 | 3 | 1 | 2 | 0 |
Sex | ||||||
Male | 73 | 68 | 68 | 71 | 62 | 81 |
Female | 100 | 104 | 105 | 101 | 110 | 93 |
Mean duration (range) of seasonal allergic rhinitis, years | 18 (2–60) | 18 (2–55) | 16 (2–50) | 17 (2–49) | 16 (2–48) | 17 (2–50) |